248 related articles for article (PubMed ID: 17400912)
21. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.
Lu TX; Liang JH; Miao Y; Fan L; Wang L; Qu XY; Cao L; Gong QX; Wang Z; Zhang ZH; Xu W; Li JY
Sci Rep; 2015 Jul; 5():12168. PubMed ID: 26202875
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus-positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations.
Hoeller S; Tzankov A; Pileri SA; Went P; Dirnhofer S
Hum Pathol; 2010 Mar; 41(3):352-7. PubMed ID: 19913281
[TBL] [Abstract][Full Text] [Related]
24. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on 'EBV-positive DLBCL of the elderly'.
Uner A; Akyurek N; Saglam A; Abdullazade S; Uzum N; Onder S; Barista I; Benekli M
APMIS; 2011 Apr; 119(4-5):309-16. PubMed ID: 21492232
[TBL] [Abstract][Full Text] [Related]
25. Impact of Epstein-Barr virus in monomorphic B-cell posttransplant lymphoproliferative disorders: a histogenetic study.
Johnson LR; Nalesnik MA; Swerdlow SH
Am J Surg Pathol; 2006 Dec; 30(12):1604-12. PubMed ID: 17122518
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and treatment outcome in a Taiwanese population of patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Lu CH; Lee KF; Chen CC; Chen YY; Huang CE; Tsai PS; Tsou HY; Chou HJ; Chen MF; Chen PT; Lee KD; Lung J
Jpn J Clin Oncol; 2014 Dec; 44(12):1164-71. PubMed ID: 25320341
[TBL] [Abstract][Full Text] [Related]
27. The impact of activated p-AKT expression on clinical outcomes in diffuse large B-cell lymphoma: a clinicopathological study of 262 cases.
Hong JY; Hong ME; Choi MK; Kim YS; Chang W; Maeng CH; Park S; Lee SJ; Do IG; Jo JS; Jung SH; Kim SJ; Ko YH; Kim WS
Ann Oncol; 2014 Jan; 25(1):182-8. PubMed ID: 24356628
[TBL] [Abstract][Full Text] [Related]
28. [Clinicopathologic and immunohistochemical study of intra-abdominal non-Hodgkin B-cell lymphoma occurring in children].
Yang WP; Zhu CD; Gong LP; Lü BB; Zou Y; Zhong HS; Xiao Q; Wu Y; Xu HY; Zeng ST; Huang H
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):759-64. PubMed ID: 20079016
[TBL] [Abstract][Full Text] [Related]
29. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
[TBL] [Abstract][Full Text] [Related]
31. High plasma EBV-DNA load and positive EBER status associated with viral recurrence and persistent infection in early treatment of lymphoma.
Zeng M; Jia Q; Chen J; Xu L; Xie L; Cheng Q; Li Q; Xiao M; Fang Z
Clin Exp Med; 2023 Aug; 23(4):1307-1316. PubMed ID: 36168074
[TBL] [Abstract][Full Text] [Related]
32. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/APC/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study.
Dupuis J; Emile JF; Mounier N; Gisselbrecht C; Martin-Garcia N; Petrella T; Bouabdallah R; Berger F; Delmer A; Coiffier B; Reyes F; Gaulard P;
Blood; 2006 Dec; 108(13):4163-9. PubMed ID: 16902151
[TBL] [Abstract][Full Text] [Related]
34. EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
Hong JY; Yoon DH; Suh C; Huh J; Do IG; Sohn I; Jo J; Jung SH; Hong ME; Yoon H; Ko YH; Kim SJ; Kim WS
Ann Oncol; 2015 Mar; 26(3):548-55. PubMed ID: 25475080
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.
Cohen M; Vistarop AG; Huaman F; Narbaitz M; Metrebian F; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2017 Sep; 7(1):10813. PubMed ID: 28883511
[TBL] [Abstract][Full Text] [Related]
36. TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
Cho J; Kim E; Yoon SE; Kim SJ; Kim WS
Cancer; 2023 May; 129(10):1502-1512. PubMed ID: 36812290
[TBL] [Abstract][Full Text] [Related]
37. Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Beltran BE; Quiñones P; Morales D; Malaga JM; Chavez JC; Sotomayor EM; Castillo JJ
Hematol Oncol; 2018 Feb; 36(1):93-97. PubMed ID: 28639256
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma.
Chao C; Silverberg MJ; Martínez-Maza O; Chi M; Abrams DI; Haque R; Zha HD; McGuire M; Xu L; Said J
Clin Cancer Res; 2012 Sep; 18(17):4702-12. PubMed ID: 22711707
[TBL] [Abstract][Full Text] [Related]
39. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
Stuhlmann-Laeisz C; Szczepanowski M; Borchert A; Brüggemann M; Klapper W
Virchows Arch; 2015 Jan; 466(1):85-92. PubMed ID: 25339301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]